We know how important it is for patients and families to be able to see visitors. Please help us keep our patients and staff as safe as possible by checking the guidance below before you visiting.
Read more on visiting times...
We recognise the impact that a long stay in hospital can have on families and the importance of maintaining strong communication. Our ward staff are keeping in touch with patients’ next of kin directly and our Voluntary Services team can help pass on personal messages from family and friends.
After suspending visiting earlier in the year, we are now able to offer limited visiting to some wards at the discretion of the nurse in-charge.”
Read more on visiting times...
We recognise the impact that a long stay in hospital can have on families and the importance of maintaining strong communication. Our ward staff are keeping in touch with patients’ next of kin directly and our Patient Advice and Liaison Service (PALS) can help pass on personal messages from family and friends.
The Queen Alexandra Hospital is located just on the hill slopes of Portsdown Hill overlooking Portsmouth. It is conveniently situated for both the M27 and A3M.
Family members and carers play an important role in supporting patients during an episode of ill health. We are committed to the active involvement of family members, friends and carers during a hospital stay. Family members and carers play an important role in supporting patients during an episode of ill health.
More information on visiting hospital for an appointment.
If you've had experience of using our services and would like to make a comment then please contact the Patient Advice and Liaison Service (PALS). Your views are very important to us and we would like to hear where you think improvements are needed or where things have gone so well that you would like to share your thanks or gratitude with the staff involved. When things have not gone so well then you can be sure that we want to hear from you, so please get in touch with PALS.
Our Strategy – Working Together, Improving Together
Our strategy sets out our vision, values, strategic aims and most importantly, how we will deliver against these ambitions for our patients, communities, and people in the future.
It is not just a document, it is for and about everyone at PHU, building on what we have achieved with a renewed focus on continuous improvement and the need to continue to work together and improve together to achieve our goals.
A full copy of the strategy can be downloaded here.
For more information, please visit our strategy webpage.
There are lots of opportunities for you to get involved with the Trust, from volunteering to attending our public meetings, our Annual General Meeting or our hospital open day which is held every year.
We welcome and value your feedback and use the views you share with us in a number of ways to learn and make improvements as well as sharing best practice. Feedback can be provided in a number of ways.
Date: 28 June 2023
A new trial is investigating a COVID-19 booster vaccine designed to protect against multiple variants.
Local people are invited to come forward to take part in an important research study at the Portsmouth Research Hub, supported by Portsmouth Hospitals University NHS Trust and the National Institute for Health and Care Research (NIHR) in Wessex.
UK-wide research effort
More than one million people have taken part in COVID-19 research across the UK. Thanks to your efforts, we now have effective vaccines and treatments.
Professor Saul Faust, Clinical Director of the NIHR Clinical Research Network (CRN) Wessex, said: “Public participation in COVID-19 research is still vital to enable effective treatments to be identified, evidenced and made available to NHS patients. We are inviting people to take part in this important study for a vaccine that may protect against multiple variants, including the Omicron variant.”
Mark Roland, Acting Medical Director in Portsmouth added: "Despite vaccines, some people still get severe Covid. We know the virus is continually evolving, and vaccines are constantly changing to combat these new variants. The more people who participate in vaccine studies, the better prepared we are to stay ahead of the virus and protect ourselves and our communities even as new variants emerge."
Take part
The new COVID-19 booster vaccine has been developed by Moderna. The NextCOVE Study is open to people aged 18 and older who have received a COVID-19 vaccine and at least one booster dose. Eligible participants will receive payment for trial-related time and travel. Please visit www.nextcovestudyuk.com and select Portsmouth as your preferred site. The hub is located in the John Pounds Community Centre.
First Participant - Alison Kalus
Alison Kalus, 59, a retired consultant from Hampshire, was the first person to take part in the trial in Portsmouth, and across the Wessex region.
“I am really happy to help with clinical research because hopefully it will help save lives in the future,” she said. “I've got two elderly parents I spend a lot of time with, and a very vulnerable friend, so I am very conscious of protecting them against COVID-19, and by doing this I get another booster. I also took part in the COV-BOOST trial so when the research nurse called and asked me to take part again, I was happy to agree."
Ongoing research
A number of approved COVID-19 vaccines are now available, but it is still very important to take part in new research.
Different vaccines and dose schedules are needed for different groups of people. Several COVID-19 vaccine studies are still running in the UK, which need more volunteers to step forward.
Dr Patrick Moore, Principal Investigator and Co-Director of the NIHR CRN Wessex, said:"We have been overwhelmed by the response from our local communities in the search for better vaccines.
“I would like to thank these volunteers for their continued support and for stepping forward to take part in our vital ongoing research.
“It is important we continue the fight against COVID-19 and its evolving variants, to develop new and improved vaccines to protect the most vulnerable and inform future vaccine booster programmes."
ends
